caspofungina sandoz 70 mg
lek pharmaceuticals d.d. - slovenia - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice
posaconazol mylan 40 mg/ml
genepharm s.a. - grecia - posaconazolum - susp. orala - 40mg/ml - antimicotice de uz sistemic derivati de triazol
posaconazol flomi 40 mg/ml
genepharm s.a. - grecia - posaconazolum - susp. orala - 40mg/ml - antimicotice de uz sistemic derivati de triazol
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - carcinom, celule scuamoase - agenți antineoplazici - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
cancidas 50 mg pulbere pentru concentrat pentru soluţie perfuzabilă
merck sharp & dohme b.v. - caspofunginum - pulbere pentru concentrat pentru soluţie perfuzabilă - 50 mg
cancidas 70 mg pulbere pentru concentrat pentru soluţie perfuzabilă
merck sharp & dohme b.v. - caspofunginum - pulbere pentru concentrat pentru soluţie perfuzabilă - 70 mg
myfortic 180 mg comprimate gastrorezistente
novartis pharma ag - acid mycophenolicum - comprimate gastrorezistente - 180 mg
posaconazol flomi 40 mg/ml
genepharm s.a. - grecia - posaconazolum - susp. orala - 40mg/ml - antimicotice de uz sistemic derivati de triazol
caspofungina galenicum health 50 mg
pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice
caspofungina galenicum health 70 mg
pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice